Merck KGaA (VIE:MRCK)
Austria · Delayed Price · Currency is EUR | Market Cap | 47.46B -5.3% |
| Revenue (ttm) | 21.10B -0.3% |
| Net Income | 2.61B -6.1% |
| EPS | 6.00 -6.1% |
| Shares Out | n/a |
| PE Ratio | 18.20 |
| Forward PE | 14.07 |
| Dividend | 2.20 (1.88%) |
| Ex-Dividend Date | Apr 27, 2026 |
| Volume | 12 |
| Average Volume | 5 |
| Open | 112.60 |
| Previous Close | 109.40 |
| Day's Range | 110.70 - 112.60 |
| 52-Week Range | 100.60 - 131.45 |
| Beta | n/a |
| RSI | 46.74 |
| Earnings Date | May 13, 2026 |
About Merck KGaA
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry... [Read more]
Financial Performance
In 2025, Merck KGaA's revenue was 21.10 billion, a decrease of -0.26% compared to the previous year's 21.16 billion. Earnings were 2.61 billion, a decrease of -6.09%.
Financial StatementsNews
At Kenya State House, Merck Foundation in Partnership With Kenya First Lady and Ministry of Gender Launch Their "Educating Linda" Program to Support Girl Education
Business Wire IndiaMerck Foundation, the philanthropic arm of Merck KGaA Germany officially launched their Educating Linda program in Kenya in partnership with The First Lady of Kenya & Ambassador of…
Merck Foundation Marks 'World Art Day' by Celebrating the 6 Year Anniversary of Their 'Fashion and Art With Purpose' Community Established in 2020
Business Wire IndiaMerck Foundation, the philanthropic arm of Merck KGaA Germany, marks World Art Day 2026 through their Pan-African “Art and Fashion with Purpose” community, established by Dr. Rasha ...
MilliporeSigma Launches 2026 Global Curiosity Cube Tour, Bringing STEM Learning to Students
NORTHAMPTON, MA / ACCESS Newswire / April 14, 2026 / The Curiosity Cube, a mobile science lab from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has b...
Merck Foundation Chairman and CEO meet Gabon First Lady to launch their long-term partnership to advance healthcare and support girls' education
Business Wire IndiaMerck Foundation, the philanthropic arm of Merck KGaA Germany officially launched their programs in partnership with H.E. Madam ZITA OLIGUI NGUEMA, The First Lady of Gabonese Republ...
Merck Foundation CEO Together With African and Asian First Ladies Mark World Health Day 2026 by Providing Over 2,600 Scholarships for Healthcare Providers Across Africa and Asia
Business Wire IndiaMerck Foundation, the philanthropic arm of Merck KGaA Germany commemorates World Health Day 2026 in partnership with First Ladies of African and Asian Countries, who are also the…
TrumpRx lists many medicines at prices higher than paid in UK
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those ...
Merck KGaA Earnings Call Transcript: Q4 2025
Solid organic growth in Life Science and Healthcare offset macro and FX headwinds, with Electronics rebounding on AI-driven demand. 2026 guidance anticipates stable margins, mid-single-digit Life Science growth, and continued strength in Semiconductor Materials.
Merck KGaA Earnings Call Transcript: Q4 2025
Delivered stable 2025 results with EUR 21.1 billion in sales and EUR 6.1 billion EBITDA, overcoming FX and geopolitical headwinds. 2026 guidance reflects cautious outlook amid MAVENCLAD U.S. patent expiry and currency risks, with growth expected in Life Science and Electronics.
Germany's Merck KGaA Expects Currency Headwinds to Weigh on Earnings
The company anticipates currency headwinds would continue to weigh on its earnings this year, as the life-sciences and chemical company prepares for a leadership change.
Merck KGaA sees earnings decline of up to 4%
Germany's Merck KGaA said on Thursday it expects 2026 adjusted operating profit to slip by up to 4%, excluding currency effects.
Merck KGaA Transcript: 44th Annual J.P. Morgan Healthcare Conference
Positioned for growth in innovation-driven markets, the group focuses on Process Solutions, rare diseases, and Semiconductor Solutions, supported by disciplined M&A and a customer-centric reorganization. Midterm guidance targets mid-single digit organic growth, with margin expansion and robust pipeline development, especially in rare diseases.
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
The Munich Regional Court ruled there was imminent infringement for Merck & Co.'s Keytruda SC in Germany related to Halozyme's MDASE patents in Europe, the San Diego company said.
Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal
Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially worth over $3 billio...
Valo Health Announces Collaboration with Merck KGaA, Darmstadt, Germany to Discover and Develop Novel Treatments for Parkinson's Disease and Related Disorders
LEXINGTON, Mass.--(BUSINESS WIRE)--Valo Health announces collaboration with Merck KGaA, Darmstadt, Germany to discover and develop novel treatments for Parkinson's and related disorders.
Merck KGaA Earnings Call Transcript: Q3 2025
Q3 2025 saw solid organic growth across all sectors, with Life Science and Healthcare leading and improved profitability from the Springworks acquisition. Full-year guidance was narrowed, with FX headwinds and Mavenclad US generic entry as key risks.
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
Merck KGaA's sales grew 5.2%, driven by demand for pharma-production products, rare diseases treatments and semiconductor materials in its electronics unit.
Merck KGaA's Q3 profit rises, beats market view
Merck KGaA reported on Thursday a slight gain in quarterly operating earnings that beat market expectations, benefiting from legislative changes in South America and the sale of a priority review vouc...
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move com...
Trump announces efforts to expand access to IVF drugs
President Donald Trump announced two new efforts to expand availability of in vitro fertilization, the first concrete step from the Trump administration on the expensive, decades-old procedure. It inc...
Trump Announces Deal With Germany's Merck on IVF Costs
President Donald Trump announces a deal with Germany's Merck KGaA to cut the price of some of its fertility medicines in exchange for relief from threatened tariffs. He speaks during a a press confere...
Merck KGaA Transcript: CMD 2025
Disciplined capital allocation and strategic M&A are sharpening sector focus and driving growth in process solutions, rare diseases, and semiconductor solutions. The group targets mid-single digit organic growth and 100 bps margin improvement over the midterm, with innovation, sustainability, and operational excellence as key enablers.
Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
The company confirmed its 2025 guidance and is targeting annual organic sales growth in the mid-single-digit percentage range and an expansion in profitability over the medium term.
Germany's Merck tweaks mid-term healthcare unit guidance
German pharmaceuticals and technology company Merck KGaA slightly improved its mid-term guidance for its healthcare business ahead of its capital markets day on Thursday.
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
Police in China are investigating an app fraud case, said German healthcare firm Merck KGaA , amid growing concerns over entities claiming affiliation with major corporations.
Merck and Siemens Deepen Strategic Partnership to Accelerate AI and Data-Driven Drug Discovery and Development
DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, and Siemens, a leading technology company, signed a new Memorandum of Understanding (MoU), extending their strateg...